◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Kirin Holdings Company, Limited (2503)

Name: Kirin Holdings Company, Limited（2503）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Consumer Defensive · ウォール街（米国） · 最終更新: 2026-09-20

Kirin Holdings Company, Limited engages in food and beverages, alcoholic beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, soft drinks, dairy products, margarine, jams, and honey. It engages in the management and operation of a chain of Kirin City beer pubs. The company also produces and sells pharmaceutical products. In addition, it manufactures and sells amino acids and nucleic acids for pharmaceutical and industrial use, as well as bulk pharmaceuticals, machines, cosmetics, and health foods.

主要指標

時価総額: JPY 2.26 trillion
売上高（2025-12-31 期末の会計年度）: JPY 2.43T
当期純利益: JPY 147.5B
売上総利益率: 47.6%
純利益率: 6.1%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
売上高合計	JPY 2.43T	JPY 2.34T	JPY 2.13T	JPY 1.99T	—
売上総利益	JPY 1.16T	JPY 1.07T	JPY 963.5B	JPY 905.7B	—
営業利益（EBIT）	JPY 209.7B	JPY 125.3B	JPY 150.3B	JPY 116.0B	—
当期純利益	JPY 147.5B	JPY 58.2B	JPY 112.7B	JPY 111.0B	—

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は 2503 のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/2503

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.